In spite of billions of dollars expended on cancer research every year, the incidence rate and
the mortality rate due to this widespread disease has increased drastically over the last few …

The past few decades have witnessed widespread research to challenge carcinogenesis;
however, it remains one of the most important health concerns with the worst prognosis and …

Natural compounds have enormous biological and clinical activity against dreadful diseases
such as cancer, as well as cardiovascular and neurodegenerative disorders. In spite of the …

Background Despite the major advances made in the field of cancer biology, it still remains
one of the most fatal diseases in the world. It is now well established that natural products …

Natural products have antitumor, anti‐inflammatory, antioxidant, and other pharmacological
activities and are an important source of drugs for prevention and treatment of various …

Objective: Venous thromboembolism (VTE) is a life-threatening complication that may
exacerbate cancer prognosis. Whilst some studies indicate an increased risk of VTE in …

Colorectal cancer (CRC) is the third most common malignancy in men and the second in
women and the fourth cause of cancer death. Survival rates decrease greatly according to …

Aims To examine the real-world safety of adding bevacizumab to first-line irinotecan-based
chemotherapy for patients with metastatic colorectal cancer (mCRC). Materials and methods …

Hypertension is a common comorbidity in patients receiving antiangiogenic therapy. Prior
studies have reported worsening or new‑onset hypertension as an adverse event of …

Background Metastatic colorectal cancer (mCRC) is increasingly treated using targeted
therapies. Post-marketing safety of these agents is understudied, especially in the elderly …